Variant report
Variant | nsv964260 |
---|---|
Chromosome Location | chr4:142413497-142434363 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548286577 | chr4:142413523-142413524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529351008 | chr4:142413535-142413536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185835710 | chr4:142413539-142413540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370884560 | chr4:142413540-142413541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79360052 | chr4:142413560-142413561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558322014 | chr4:142413561-142413562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570459992 | chr4:142413587-142413588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148174679 | chr4:142413590-142413591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375706560 | chr4:142413605-142413606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147937158 | chr4:142413612-142413613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141832582 | chr4:142413627-142413628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10519602 | chr4:142413650-142413651 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs542630164 | chr4:142413652-142413653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145023883 | chr4:142413688-142413689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576421277 | chr4:142413731-142413732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544039501 | chr4:142413746-142413747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565453747 | chr4:142413797-142413798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577252081 | chr4:142413848-142413849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191090915 | chr4:142413892-142413893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560058940 | chr4:142413904-142413905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551618813 | chr4:142413937-142413938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138544733 | chr4:142413957-142413958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563643981 | chr4:142413997-142413998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529694454 | chr4:142414056-142414057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138865749 | chr4:142414060-142414061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563437304 | chr4:142414272-142414273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530980791 | chr4:142414291-142414292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530519456 | chr4:142414348-142414349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374763917 | chr4:142414360-142414361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141999235 | chr4:142414484-142414485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182705660 | chr4:142414497-142414498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534476486 | chr4:142414593-142414594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546514742 | chr4:142414614-142414615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568220051 | chr4:142414636-142414637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188957636 | chr4:142414678-142414679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554661084 | chr4:142414692-142414693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576505718 | chr4:142414732-142414733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537525797 | chr4:142414738-142414739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559057722 | chr4:142414779-142414780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs367678661 | chr4:142414789-142414790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114586758 | chr4:142414822-142414823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546394579 | chr4:142414828-142414829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547509664 | chr4:142414829-142414830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146336897 | chr4:142414843-142414844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560003552 | chr4:142414845-142414846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182849021 | chr4:142414886-142414887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575022536 | chr4:142414903-142414904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541857560 | chr4:142414920-142414921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550439130 | chr4:142414930-142414931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563116634 | chr4:142414932-142414933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 22048815 | CNVD |
Autism | 22241247 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:142411000-142417800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:142418400-142419400 | Enhancers | GM12878-XiMat | blood |
3 | chr4:142421400-142421800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr4:142421800-142422200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr4:142422200-142423200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr4:142422200-142424400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr4:142422800-142423600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr4:142423000-142423600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr4:142423200-142423600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr4:142423200-142423600 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr4:142423200-142424000 | Enhancers | Adipose Nuclei | Adipose |
12 | chr4:142423400-142424000 | Enhancers | NHDF-Ad | bronchial |
13 | chr4:142423600-142423800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr4:142423600-142423800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr4:142423800-142424000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr4:142424000-142424200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr4:142430400-142431400 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
18 | chr4:142431000-142431200 | ZNF genes & repeats | IMR90 fetal lung fibroblasts Cell Line | lung |
19 | chr4:142431000-142431200 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
20 | chr4:142431200-142431800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
21 | chr4:142432200-142433000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |